GlassScriptPhysician profile
Thomas J Calvert
NPI 1982042677
$3,219.03
in general payments reported to CMS, 2019-2025
30 companies · $1,140 in 2025
The $1,140 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $164 · 2021: $224 · 2022: $821 · 2023: $341 · 2024: $529 · 2025: $1,140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,010.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,009.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $497.05 | 2020-2025 | |
| Teleflex LLC | $456.48 | 2022-2024 | Urolift, Solesta |
| Calyxo, INC. | $306.16 | 2025 | Cvac Aspiration System |
| Boston Scientific Corporation | $225.69 | 2022-2025 | Rezum Generator, Bulkamid, Solyx Blue |
| Medtronic, INC. | $223.80 | 2022-2025 | Interstim |
| Pfizer INC. | $199.62 | 2023-2025 | |
| Astellas Pharma US INC | $158.31 | 2021-2025 | Xtandi |
| Procept Biorobotics Corporation | $139.25 | 2024 | Aquabeam System |
| Abbvie INC. | $137.38 | 2022-2025 | Botox, Lupron Depot |
| Bluewind Medical | $108.62 | 2024 | Revi |
| Endo Pharmaceuticals INC. | $93.37 | 2020-2022 | |
| Axonics, INC. | $92.15 | 2020-2023 | Bulkamid, Axonics |
| Urogen Pharma, INC. | $79.57 | 2020-2022 | |
| Stryker Corporation | $60.92 | 2023-2024 | Fluid Management System |
| Myriad Genetic Laboratories, INC. | $43.68 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $41.59 | 2024 | Stratafix, Vistaseal |
| Dendreon Pharmaceuticals LLC | $40.60 | 2025 | Provenge |
| Progenics Pharmaceuticals, INC. | $40.10 | 2024 | |
| Sagent Pharmaceuticals | $38.56 | 2020-2021 | |
| Immunitybio, INC. | $30.09 | 2025 | |
| Laborie Medical Technologies Corp. | $25.83 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Tolmar Pharmaceuticals, INC. | $25.12 | 2022 | |
| Steris Corporation | $24.93 | 2025 | |
| Cook Medical LLC | $24.57 | 2023 | Resonance |
| Urovant Sciences INC | $23.75 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $22.60 | 2023 | Jynarque |
| Abbott Laboratories | $19.03 | 2024 | Eterna |
| Innovation Technologies INC | $15.07 | 2024 | Irrisept |
| Bayer Healthcare Pharmaceuticals INC. | $13.40 | 2020 | |
| Dentsply Ih INC. | $11.74 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Calvert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.